Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blinded, Placebo-Controlled, Randomized Study to Evaluate the Efficacy and Tolerability of a Daily Serum

NCT05514782 is registered in ClinicalTrials.gov with Revision Skincare as lead sponsor.

NCT NCT05514782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05514782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blinded, Placebo-Controlled, Randomized Study to Evaluate the Efficacy and Tolerability of a Daily Serum
Lead sponsor
Revision Skincare
Phase
Not applicable
Overall status
Completed
Start date
September 15, 2021
Completion date
December 10, 2021
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

photoaging, wrinkle